Mesalazin Orion

Mesalazine, the active ingredient in Mesalazin Orion, is a 5-aminosalicylic acid (5-ASA) anti‑inflammatory agent presented as a rectal formulation for local use. It is used to reduce inflammation in the colon of patients with ulcerative colitis and proctitis.

GNH USA supplies Mesalazin Orion as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mesalazin Orion, a 5‑aminosalicylic acid anti‑inflammatory agent, is used in the management of inflammatory bowel disease.

- Ulcerative colitis: helps induce and maintain remission by reducing colonic inflammation. - Proctitis: provides targeted relief of inflammation in the rectal mucosa, improving symptoms.

Mesalazin Orion may be associated with a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache: mild to moderate headache. - Nausea: occasional nausea. - Abdominal pain: mild cramping. - Diarrhea: loose stools.

Serious or Rare Side Effects: - Severe hypersensitivity reactions: rash, fever, eosinophilia. - Hepatotoxicity: elevated liver enzymes indicating liver injury. - Nephrotoxicity: impaired kidney function that may require monitoring.

Before initiating therapy, clinicians should consider several safety measures.

- Renal function monitoring: assess kidney function before and during treatment. - Hepatic function monitoring: check liver enzymes periodically. - Blood counts: perform regular complete blood count to detect cytopenias. - Pregnancy: use only if potential benefit justifies risk; consult a physician. - Concomitant NSAIDs: avoid or use with caution due to increased nephrotoxicity risk. - Store at room temperature: keep below 25°C, retain in original packaging, protect from moisture.

Mesalazin Orion can interact with other medicines; some require avoidance while others need close monitoring.

Major Interactions (Avoid): - Azathioprine: increased risk of bone marrow suppression. - Anticoagulants (e.g., warfarin): may enhance anticoagulant effect.

Moderate Interactions (Monitor Closely): - NSAIDs: additive renal toxicity. - Oral corticosteroids: may increase infection risk. - Lithium: possible alteration of lithium levels.